revaprazan
Sign in to saveRevaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis. It acts as an acid pump antagonist (potassium-competitive acid blocker). Revaprazan is approved for use in South Korea, but is not approved in Europe or the United States.
Wikidata facts
- Mass
- 362.191
Show 2 more facts
- canonical SMILES
- CC1C2=CC=CC=C2CCN1C3=NC(=NC(=C3C)C)NC4=CC=C(C=C4)F
- chemical formula
- C₂₂H₂₃FN₄
Sources (2)
via Wikidata · CC0
~1 min read
Article
2 sectionsContents
- See also
- References
Revaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis. It acts as an acid pump antagonist (potassium-competitive acid blocker). Revaprazan is approved for use in South Korea, but is not approved in Europe or the United States.
==See also== Vonoprazan
Connections
medication
Entity
digital object identifier
Entity
chemical formula
Entity
gastritis
Entity
molar mass
Entity
peptic ulcer disease
Entity
Q180686
Entity
CAS Registry Number
Entity
gastroesophageal reflux disease
Entity
gastrointestinal tract
Entity
PubChem
Entity
Anatomical Therapeutic Chemical Classification System
Entity
gastric acid
Entity
omeprazole
Entity
prostaglandins
Entity
World Health Organization Model List of Essential Medicines
Entity
clinical trial
Entity
simplified molecular input line entry specification
Entity
ranitidine
Entity
IUPAC nomenclature of chemistry
Entity